192 related articles for article (PubMed ID: 34496895)
21. Corneal Substructure Dosimetry Predicts Corneal Toxicity in Patients With Uveal Melanoma Treated With Proton Beam Therapy.
Lee HJ; Stacey A; Klesert TR; Wells C; Skalet AH; Bloch C; Fung A; Bowen SR; Wong TP; Shibata D; Halasz LM; Rengan R
Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):374-382. PubMed ID: 30763658
[TBL] [Abstract][Full Text] [Related]
22. Clinical Outcomes of Proton Radiotherapy for Uveal Melanoma.
Verma V; Mehta MP
Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e17-27. PubMed ID: 26915706
[TBL] [Abstract][Full Text] [Related]
23. Practice Patterns Analysis of Ocular Proton Therapy Centers: The International OPTIC Survey.
Hrbacek J; Mishra KK; Kacperek A; Dendale R; Nauraye C; Auger M; Herault J; Daftari IK; Trofimov AV; Shih HA; Chen YE; Denker A; Heufelder J; Horwacik T; Swakoń J; Hoehr C; Duzenli C; Pica A; Goudjil F; Mazal A; Thariat J; Weber DC
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):336-343. PubMed ID: 27084651
[TBL] [Abstract][Full Text] [Related]
24. Salvage proton beam therapy in local recurrent uveal melanoma.
Riechardt AI; Cordini D; Dobner B; Seibel I; Gundlach E; Rehak M; Hager A; Stark R; Moser L; Joussen AM
Am J Ophthalmol; 2014 Nov; 158(5):948-56. PubMed ID: 25038327
[TBL] [Abstract][Full Text] [Related]
25. [Psychological aspects and quality of life in uveal melanoma patients during the treatment process by ocular bulb remotion].
Amaro TA; Yazigi L; Erwenne C
Arq Bras Oftalmol; 2006; 69(6):889-94. PubMed ID: 17273685
[TBL] [Abstract][Full Text] [Related]
26. Uveal Melanoma Metastasis to the Contralateral Eye Structures: A Retrospective Comparative Analysis of 13 Consecutive Patients.
Masoomian B; Mashayekhi A; Shields JA; Shields CL
Ophthalmol Retina; 2021 Oct; 5(10):1036-1042. PubMed ID: 33421627
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
[TBL] [Abstract][Full Text] [Related]
28. Effects of plaque brachytherapy and proton beam radiotherapy on prognostic testing: a comparison of uveal melanoma genotyped by microsatellite analysis.
Thornton S; Coupland SE; Heimann H; Hussain R; Groenewald C; Kacperek A; Damato B; Taktak A; Eleuteri A; Kalirai H
Br J Ophthalmol; 2020 Oct; 104(10):1462-1466. PubMed ID: 32024655
[TBL] [Abstract][Full Text] [Related]
29. Uveal melanoma: quantitative evaluation of diffusion-weighted MR imaging in the response assessment after proton-beam therapy, long-term follow-up.
Foti PV; Longo A; Reibaldi M; Russo A; Privitera G; Spatola C; Raffaele L; Salamone V; Farina R; Palmucci S; Musumeci A; Caltabiano R; Ragusa M; Mariotti C; Avitabile T; Milone P; Ettorre GC
Radiol Med; 2017 Feb; 122(2):131-139. PubMed ID: 27752969
[TBL] [Abstract][Full Text] [Related]
30. Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.
Petrovic A; Bergin C; Schalenbourg A; Goitein G; Zografos L
Ophthalmology; 2014 Apr; 121(4):898-904. PubMed ID: 24405742
[TBL] [Abstract][Full Text] [Related]
31. Depression in Choroidal Melanoma Patients Treated with Proton Beam Radiotherapy.
Moschos MM; Moustafa GA; Lavaris A; Damaskos C; Laios K; Karathanou E; Ladas DS; Asproudis I; Garmpis N; Kalogeropoulos C
Anticancer Res; 2018 May; 38(5):3055-3061. PubMed ID: 29715140
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
[TBL] [Abstract][Full Text] [Related]
33. Quality of Life Concerns in Patients with Uveal Melanoma after Initial Diagnosis.
Barker CA; Kozlova A; Shoushtari AN; Hay JL; Francis JH; Abramson DH
Ocul Oncol Pathol; 2020 May; 6(3):184-195. PubMed ID: 32509764
[TBL] [Abstract][Full Text] [Related]
34. Quality of Life in Uveal Melanoma Patients in Ireland: A Single-Centre Survey.
Scannell O; O'Neill V; Dunne M; Baily C; Salih A; Cunningham M; Horgan N
Ocul Oncol Pathol; 2020 Mar; 6(2):99-106. PubMed ID: 32258017
[TBL] [Abstract][Full Text] [Related]
35. Role of vitreoretinal surgery in maximizing treatment outcome following complications after proton therapy for uveal melanoma.
Tran BK; Schalenbourg A; Bovey E; Zografos L; Wolfensberger TJ
Retina; 2013 Oct; 33(9):1777-83. PubMed ID: 23792487
[TBL] [Abstract][Full Text] [Related]
36. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma.
Egger E; Schalenbourg A; Zografos L; Bercher L; Boehringer T; Chamot L; Goitein G
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):138-47. PubMed ID: 11516863
[TBL] [Abstract][Full Text] [Related]
37. [Quality of life and psychological state in patients with choroidal melanoma: longitudinal study].
Suchocka-Capuano A; Brédart A; Dolbeault S; Rouic LL; Lévy-Gabriel C; Desjardins L; Flahault C; Bungener C
Bull Cancer; 2011 Feb; 98(2):97-107. PubMed ID: 21382791
[TBL] [Abstract][Full Text] [Related]
38. Radiation therapy for uveal melanoma: a review of treatment methods available in 2021.
Reichstein DA; Brock AL
Curr Opin Ophthalmol; 2021 May; 32(3):183-190. PubMed ID: 33770014
[TBL] [Abstract][Full Text] [Related]
39. Local recurrence of uveal melanoma after proton beam therapy.
Silva-Rodríguez P; Bande Rodríguez MF; Santiago Varela M; Ruiz-Oliva F; Pardo Perez M; Blanco-Teijeiro MJ; de Trocóniz LLF; Piñeiro Ces A
Clin Exp Optom; 2020 Jul; 103(4):548-549. PubMed ID: 31711260
[No Abstract] [Full Text] [Related]
40. Proton therapy for the management of uveal melanoma and other ocular tumors.
Mishra KK; Daftari IK
Chin Clin Oncol; 2016 Aug; 5(4):50. PubMed ID: 27558251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]